Kos Pharmaceuticals To Report Third Quarter Results On November 9, 2006 Conference Call At 8:30 A.M. ET
CRANBURY, N.J.--(BUSINESS WIRE)--Kos Pharmaceuticals, Inc. (Nasdaq:KOSP), a fully integrated specialty pharmaceutical company, will announce results for the third quarter ended September 30, 2006, before the market opens on Thursday, November 9, 2006.